|
US6187777B1
(en)
|
1998-02-06 |
2001-02-13 |
Amgen Inc. |
Compounds and methods which modulate feeding behavior and related diseases
|
|
HUP0104987A3
(en)
|
1998-12-18 |
2002-09-30 |
Axys Pharmaceuticals Inc South |
Benzimidazole or indole derivatives protease inhibitors, and pharmaceutical compositions containing them
|
|
WO2001029025A2
(en)
|
1999-10-19 |
2001-04-26 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
|
DE60305446T4
(de)
|
2002-01-07 |
2009-07-09 |
Eisai R&D Management Co., Ltd. |
Desazapurine und deren verwendung
|
|
FR2836915B1
(fr)
|
2002-03-11 |
2008-01-11 |
Aventis Pharma Sa |
Derives d'aminoindazoles, procede de preparation et intermediaires de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
|
|
US7410975B2
(en)
|
2003-06-20 |
2008-08-12 |
Coley Pharmaceutical Group, Inc. |
Small molecule toll-like receptor (TLR) antagonists
|
|
US20060235037A1
(en)
|
2005-04-15 |
2006-10-19 |
Purandare Ashok V |
Heterocyclic inhibitors of protein arginine methyl transferases
|
|
PT1899333E
(pt)
|
2005-06-27 |
2009-04-23 |
Sanofi Aventis |
Derivados pirazolopiridina como inibidores da cinase do receptor beta-adrenérgico 1
|
|
JP2009532501A
(ja)
|
2006-04-04 |
2009-09-10 |
ミリアド ジェネティクス， インコーポレイテッド |
疾患および障害のための化合物
|
|
DE102006033109A1
(de)
|
2006-07-18 |
2008-01-31 |
Grünenthal GmbH |
Substituierte Heteroaryl-Derivate
|
|
US8027888B2
(en)
|
2006-08-31 |
2011-09-27 |
Experian Interactive Innovation Center, Llc |
Online credit card prescreen systems and methods
|
|
ATE495743T1
(de)
|
2006-12-01 |
2011-02-15 |
Galapagos Nv |
Triazolopyridinverbindungen zur behandlung von degenerations- und entzündungskrankheiten
|
|
WO2008152471A1
(en)
|
2007-06-12 |
2008-12-18 |
Coley Pharmaceutical Group, Inc. |
Quinazoline derivative useful as toll-like receptor antagonist
|
|
WO2009030996A1
(en)
|
2007-09-05 |
2009-03-12 |
Coley Pharmaceutical Group, Inc. |
Triazole compounds as toll-like receptor (tlr) agonists
|
|
EP2205085A1
(en)
|
2007-09-25 |
2010-07-14 |
Merck Sharp & Dohme Corp. |
2-aryl or heteroaryl indole derivatives
|
|
US8354400B2
(en)
|
2008-09-26 |
2013-01-15 |
Eisai R&D Co., Ltd. |
Benzoxazole compounds and methods of use
|
|
EP2340243B1
(en)
|
2008-10-17 |
2014-10-08 |
Boehringer Ingelheim International GmbH |
Heteroaryl substituted indole compounds useful as mmp-13 inhibitors
|
|
TWI462920B
(zh)
|
2009-06-26 |
2014-12-01 |
葛萊伯格有限公司 |
用於治療退化性及發炎疾病之新穎化合物
|
|
PL2453895T3
(pl)
|
2009-07-16 |
2018-10-31 |
Mallinckrodt Llc |
(+)-morfinany jako antagonisty receptora toll-like 9 i ich zastosowania terapeutyczne
|
|
BR112012006630A2
(pt)
|
2009-09-24 |
2016-05-03 |
Hoffmann La Roche |
derivados em indol como moduladores dos canais de cálcio ativados para liberação de cálcio (crac)
|
|
AU2010310449A1
(en)
|
2009-10-22 |
2012-05-03 |
Vertex Pharmaceuticals Incorporated |
Compositions for treatment of cystic fibrosis and other chronic diseases
|
|
WO2012054862A2
(en)
|
2010-10-21 |
2012-04-26 |
The Brigham And Women's Hospital, Inc. |
Agents, compositions, and methods for treating pruritis and related skin conditions
|
|
DK2663555T3
(en)
|
2011-01-12 |
2017-03-27 |
Ventirx Pharmaceuticals Inc |
SUBSTITUTED BENZOAZEPINS AS MODULATORS OF TOLL-LIKE RECEPTORS
|
|
MX346387B
(es)
|
2011-01-12 |
2017-03-02 |
Ventirx Pharmaceuticals Inc |
Benzoazepinas sustituidas como moduladores de receptores tipo toll.
|
|
AU2012262021B2
(en)
|
2011-06-01 |
2016-07-28 |
Janus Biotherapeutics, Inc. |
Novel immune system modulators
|
|
BR112013030894A2
(pt)
|
2011-06-01 |
2016-08-16 |
Janus Biotherapeutics Inc |
moduladores do sistema imune
|
|
KR101913619B1
(ko)
|
2011-06-09 |
2018-12-28 |
리젠 파마슈티컬스 소시에떼 아노님 |
Gpr-119의 조절제로서의 신규한 화합물
|
|
CN103874702B
(zh)
|
2011-07-15 |
2015-12-09 |
杨森制药公司 |
作为γ分泌酶调节剂的经取代的吲哚衍生物
|
|
CA2850932A1
(en)
|
2011-10-04 |
2013-04-11 |
Janus Biotherapeutics, Inc. |
Novel imidazole quinoline-based immune system modulators
|
|
CA2871589C
(en)
|
2012-05-18 |
2020-12-22 |
Seiji Hori |
Pyrimidine carboxylic acid derivatives and their use as tlr7 agonists
|
|
JO3407B1
(ar)
|
2012-05-31 |
2019-10-20 |
Eisai R&D Man Co Ltd |
مركبات رباعي هيدرو بيرازولو بيريميدين
|
|
US9761813B2
(en)
|
2012-08-10 |
2017-09-12 |
Doosan Corporation |
Organic light-emitting compound and organic electroluminescent device using same
|
|
EP2738172A1
(en)
|
2012-11-28 |
2014-06-04 |
Almirall, S.A. |
New bicyclic compounds as crac channel modulators
|
|
KR101823488B1
(ko)
|
2013-10-14 |
2018-01-30 |
에자이 알앤드디 매니지먼트 가부시키가이샤 |
선택적으로 치환된 퀴놀린 화합물
|
|
US9643967B2
(en)
|
2013-12-13 |
2017-05-09 |
Takeda Pharmaceutical Company Limited |
Pyrrolo[3,2-c]pyridine derivatives as TLR inhibitors
|
|
CN112898308B
(zh)
|
2014-08-15 |
2026-08-07 |
正大天晴药业集团股份有限公司 |
作为tlr7激动剂的吡咯并嘧啶化合物
|
|
US20170275287A1
(en)
|
2014-08-22 |
2017-09-28 |
Janus Biotherapeutics, Inc. |
Novel n2, n4, n7, 6-tetrasubstituted pteridine-2,4,7-triamine and 2, 4, 6, 7-tetrasubstituted pteridine compounds and methods of synthesis and use thereof
|
|
US10071079B2
(en)
|
2016-06-29 |
2018-09-11 |
Bristol-Myers Squibb Company |
[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds
|
|
CN109715617B
(zh)
|
2016-07-30 |
2022-04-19 |
百时美施贵宝公司 |
作为tlr7、tlr8或tlr9抑制剂的二甲氧基苯基取代的吲哚化合物
|
|
ES2902504T3
(es)
|
2016-09-09 |
2022-03-28 |
Bristol Myers Squibb Co |
Compuestos de indol sustituidos con piridilo
|
|
EA202091474A1
(ru)
*
|
2017-12-19 |
2020-11-18 |
Бристол-Маерс Сквибб Компани |
Замещенные индольные соединения, применимые в качестве ингибиторов tlr
|